Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.102 USD | +13.97% | +11.48% | -39.86% |
Mar. 27 | Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab | CI |
Feb. 15 | Kintara Therapeutics Continues to Evaluate Strategic Options | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-39.86% | 3.49M | |
+2.91% | 108B | |
+9.91% | 104B | |
+6.58% | 23.66B | |
-12.46% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-12.89% | 16.19B | |
+4.80% | 13.72B | |
+34.62% | 12.22B |
- Stock
- Equities
- Stock Kintara Therapeutics, Inc. - Nasdaq
- News Kintara Therapeutics, Inc.
- Sector Update: Health Care Stocks Edging Higher This Afternoon